Company Filing History:
Years Active: 2024-2025
Title: Gregory William Haslett: Innovator in Pharmaceutical Compounds
Introduction
Gregory William Haslett is a notable inventor based in Slough, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address disorders caused by IgE. With a total of 2 patents, Haslett's work is recognized for its potential impact on allergy treatments and autoimmune responses.
Latest Patents
Haslett's latest patents include innovative compounds such as tetrahydrobenzo-quinoline sulfonamides derivative compounds. This invention relates to derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them, and their use in treating disorders caused by IgE, including allergic responses and certain autoimmune responses. Another significant patent involves thiophene derivatives for the treatment of disorders caused by IgE. These compounds, along with their pharmaceutically acceptable salts, are designed to treat or prevent conditions such as allergy and type 1 hypersensitivity.
Career Highlights
Gregory William Haslett is currently associated with Ucbbiopharma Srl, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for complex health issues.
Collaborations
Haslett collaborates with esteemed colleagues, including Timothy John Norman and Oliver Philps, contributing to a dynamic research environment that fosters innovation.
Conclusion
Gregory William Haslett's contributions to pharmaceutical inventions highlight his role as a key innovator in the field. His patents reflect a dedication to improving health outcomes for individuals affected by IgE-related disorders.